{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:15:26Z","timestamp":1791040526486,"version":"4.1.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":148,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009780","name":"Region Sk\u00e5ne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of rare, autoimmune diseases causing inflammation in the vessel wall. Many organs can be affected, and kidney involvement is a common and serious manifestation. Complement activation is important in disease development and has also been detected in patients in remission. The reason for increased complement activation also without active disease is not understood.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this study, 65 AAV patients in remission, contributing with a total of 147 plasma samples, were included. Biomarkers of complement activation such as C4d (classical and lectin pathways), C3bBbP (alternative pathway), and soluble terminal complement complex (sTCC) (common terminal pathway) were measured with ELISA. For C4d measurement, an improved assay with an antibody targeting a cleavage neoepitope solely exposed during complement activation was used.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Our first hypothesis was that patients prone to recurrent flares might have an increased complement activation even when beeing in remission. However, we found no significant difference between those who did and did not develop flares during follow-up, nor any correlation between the total number of flares and any of the complement biomarkers. Interestingly, higher sTCC levels in remission correlated significantly to kidney involvement at the time of diagnosis and plasma creatinine levels at the time of sampling. Also, the diagnosis of microscopic polyangiitis (MPA), compared to granulomatosis with polyangiitis (GPA), yielded higher sTCC levels, and plasma C-reactive protein levels correlated significantly to sTCC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>These findings suggest that persistent complement activation during remission in AAV may reflect underlying disease severity and organ involvement rather than predicting future flares.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cei\/uxaf037","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T16:20:37Z","timestamp":1748535637000},"source":"Crossref","is-referenced-by-count":8,"title":["Complement factors as biomarkers in ANCA-associated vasculitis in remission"],"prefix":"10.1093","volume":"219","author":[{"given":"Rebecca","family":"Trattner","sequence":"first","affiliation":[{"name":"Department of Translational Medicine, Division of Medical Protein Chemistry, Lund University ,","place":["Sweden"]},{"name":"Department of Clinical Chemistry and pharmacology , Office for Medical services, Region Sk\u00e5ne ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Iordanou","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Division of Nephrology, Lund University, Sk\u00e5ne University Hospital ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Ohlsson","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Division of Nephrology, Lund University, Sk\u00e5ne University Hospital ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Division of Medical Protein Chemistry, Lund University ,","place":["Sweden"]},{"name":"Department of Clinical Chemistry and pharmacology , Office for Medical services, Region Sk\u00e5ne ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e5rten","family":"Segelmark","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Division of Nephrology, Lund University, Sk\u00e5ne University Hospital ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1348-1734","authenticated-orcid":false,"given":"Anna M","family":"Blom","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Division of Medical Protein Chemistry, Lund University ,","place":["Sweden"]},{"name":"Department of Clinical Chemistry and pharmacology , Office for Medical services, Region Sk\u00e5ne ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"2025062505520005500_CIT0001","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/ard.2010.137778","article-title":"Long-term patient survival in ANCA-associated vasculitis","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2025062505520005500_CIT0002","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1093\/ndt\/gfh161","article-title":"ANCA-associated vasculitis with renal involvement: an outcome analysis","volume":"19","author":"Weidner","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"2025062505520005500_CIT0003","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/ard.2009.109389","article-title":"Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis","volume":"69","author":"Little","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2025062505520005500_CIT0004","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.2215\/CJN.01020113","article-title":"Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis","volume":"8","author":"de Joode","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025062505520005500_CIT0005","doi-asserted-by":"publisher","first-page":"e0195680","DOI":"10.1371\/journal.pone.0195680","article-title":"Hypocomplementemia is associated with worse renal survival in ANCA-positive granulomatosis with polyangiitis and microscopic polyangiitis","volume":"13","author":"Deshayes","year":"2018","journal-title":"PLoS One"},{"key":"2025062505520005500_CIT0006","doi-asserted-by":"publisher","first-page":"e0158871","DOI":"10.1371\/journal.pone.0158871","article-title":"Low Serum Complement C3 Levels at Diagnosis of Renal ANCA-Associated Vasculitis Is Associated with Poor Prognosis","volume":"11","author":"Augusto","year":"2016","journal-title":"PLoS One"},{"key":"2025062505520005500_CIT0007","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1046\/j.1365-2249.1999.00889.x","article-title":"C3 and C4 allotypes in anti-neutrophil cytoplasmic autoantibody (ANCA)-positive vasculitis","volume":"116","author":"Persson","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"2025062505520005500_CIT0008","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2353\/ajpath.2007.060573","article-title":"Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies","volume":"170","author":"Xiao","year":"2007","journal-title":"Am J Pathol"},{"key":"2025062505520005500_CIT0009","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/sj.ki.5002103","article-title":"Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice","volume":"71","author":"Huugen","year":"2007","journal-title":"Kidney Int"},{"key":"2025062505520005500_CIT0010","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1681\/ASN.2008050497","article-title":"C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis","volume":"20","author":"Schreiber","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2025062505520005500_CIT0011","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1093\/ndt\/gfv288","article-title":"Complement in ANCA-associated glomerulonephritis","volume":"32","author":"Hilhorst","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2025062505520005500_CIT0012","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.2215\/CJN.02790313","article-title":"Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN","volume":"8","author":"Gou","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025062505520005500_CIT0013","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ki.2012.313","article-title":"Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"83","author":"Gou","year":"2013","journal-title":"Kidney Int"},{"key":"2025062505520005500_CIT0014","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1002\/art.41011","article-title":"Measuring circulating complement activation products in Myeloperoxidase- and Proteinase 3-Antineutrophil cytoplasmic antibody-associated vasculitis","volume":"71","author":"Wu","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2025062505520005500_CIT0015","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/cei.13498","article-title":"The alternative complement pathway in ANCA-associated vasculitis: further evidence and a meta-analysis","volume":"202","author":"Moiseev","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"2025062505520005500_CIT0016","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.kint.2023.10.013","article-title":"Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis","volume":"105","author":"Lucientes-Continente","year":"2024","journal-title":"Kidney Int"},{"key":"2025062505520005500_CIT0017","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/annrheumdis-2013-203927","article-title":"Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials","volume":"74","author":"Robson","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2025062505520005500_CIT0018","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0140-6736(23)01524-6","article-title":"Complement in human disease: approved and up-and-coming therapeutics","volume":"403","author":"West","year":"2024","journal-title":"Lancet"},{"key":"2025062505520005500_CIT0019","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1681\/ASN.2016111179","article-title":"Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis","volume":"28","author":"Jayne","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2025062505520005500_CIT0020","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/acr2.11185","article-title":"Adjunctive treatment with avacopan, an oral C5a receptor inhibitor, in patients with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"2","author":"Merkel","year":"2020","journal-title":"ACR Open Rheumatol"},{"key":"2025062505520005500_CIT0021","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"N Engl J Med"},{"key":"2025062505520005500_CIT0022","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.molimm.2015.02.029","article-title":"Antibodies reactive to cleaved sites in complement proteins enable highly specific measurement of soluble markers of complement activation","volume":"66","author":"Blom","year":"2015","journal-title":"Mol Immunol"},{"key":"2025062505520005500_CIT0023","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2025062505520005500_CIT0024","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2025062505520005500_CIT0025","first-page":"1869","article-title":"Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation","volume":"100","author":"Mollnes","year":"2002","journal-title":"Blood"},{"key":"2025062505520005500_CIT0026","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.molimm.2013.05.221","article-title":"An international serum standard for application in assays to detect human complement activation products","volume":"56","author":"Bergseth","year":"2013","journal-title":"Mol Immunol"},{"key":"2025062505520005500_CIT0027","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nrrheum.2016.123","article-title":"ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients","volume":"12","author":"Cornec","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"2025062505520005500_CIT0028","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/03009742.2021.1989814","article-title":"Complement activation prior to symptom onset in myeloperoxidase ANCA-associated vasculitis but not proteinase 3 ANCA associated vasculitis - a Swedish biobank study","volume":"51","author":"Johansson","year":"2022","journal-title":"Scand J Rheumatol"},{"key":"2025062505520005500_CIT0029","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2025062505520005500_CIT0030","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s40620-017-0412-z","article-title":"ANCA-associated vasculitis with renal involvement","volume":"31","author":"Binda","year":"2018","journal-title":"J Nephrol"},{"key":"2025062505520005500_CIT0031","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1136\/ard-2022-222495","article-title":"Novel aspects in the pathophysiology and diagnosis of glomerular diseases","volume":"82","author":"Kronbichler","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025062505520005500_CIT0032","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1111\/j.1523-1755.2004.00632.x","article-title":"Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases","volume":"65","author":"Haas","year":"2004","journal-title":"Kidney Int"},{"key":"2025062505520005500_CIT0033","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000044876","article-title":"Compartmental localization of complement component transcripts in the normal human kidney","volume":"78","author":"Song","year":"1998","journal-title":"Nephron"},{"key":"2025062505520005500_CIT0034","doi-asserted-by":"publisher","first-page":"F516","DOI":"10.1152\/ajprenal.00604.2016","article-title":"Pericytes and immune cells contribute to complement activation in tubulointerstitial fibrosis","volume":"312","author":"Xavier","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"2025062505520005500_CIT0035","doi-asserted-by":"publisher","first-page":"582737","DOI":"10.3389\/fimmu.2020.582737","article-title":"Plasma C4d correlates with C4d deposition in kidneys and with treatment response in lupus nephritis patients","volume":"11","author":"Martin","year":"2020","journal-title":"Front Immunol"},{"key":"2025062505520005500_CIT0036","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13075-017-1470-2","article-title":"Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus","volume":"19","author":"Martin","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2025062505520005500_CIT0037","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3389\/fimmu.2020.00525","article-title":"Animal models of ANCA associated vasculitis","volume":"11","author":"Shochet","year":"2020","journal-title":"Front Immunol"},{"key":"2025062505520005500_CIT0038","doi-asserted-by":"publisher","first-page":"i60","DOI":"10.1093\/ndt\/gfu392","article-title":"The long-term outcomes of systemic vasculitis","volume":"30","author":"Westman","year":"2015","journal-title":"Nephrol Dial Transplant"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cei\/advance-article-pdf\/doi\/10.1093\/cei\/uxaf037\/63399838\/uxaf037.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/219\/1\/uxaf037\/63399838\/uxaf037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/219\/1\/uxaf037\/63399838\/uxaf037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T09:52:10Z","timestamp":1750845130000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/doi\/10.1093\/cei\/uxaf037\/8152864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,21]]}},"URL":"https:\/\/doi.org\/10.1093\/cei\/uxaf037","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"uxaf037"}}